Antipsychotic effect of cannabidiol
Zuardi, A.W.; Morais, S.L.; Guimarães, F.S.; Mechoulam, R.
Journal of Clinical Psychiatry 56(10): 485-486
1995
ISSN/ISBN: 0160-6689 PMID: 7559378 Document Number: 4999
The results indicate that cannabidiol may possess an atypical antipsychotic profile and suggest the need for more clinical studies, using a great number of patients, to test this possibility.
Document emailed within 1 workday
Related Documents
Malor, R.; Jackson, D.M.; Chesher, G.B. 1975: The effect of delta9-tetrahydrocannabinol, cannabidiol and cannabinol on ether anaesthesia in mice Journal of Pharmacy and Pharmacology 27(8): 610-612Zuardi, A.W.; Guimarães, F.S.; Moreira, A.C. 1993: Effect of cannabidiol on plasma prolactin, growth hormone and cortisol in human volunteers Brazilian Journal of Medical and Biological Research 26(2): 213-217
Hine, B.; Torrelio, M.; Gershon, S. 1975: Differential effect of cannabinol and cannabidiol on THC-induced responses during abstinence in morphine-dependent rats Research Communications in Chemical Pathology and Pharmacology 12(1): 185-188
Diurni, M.; Baranzini, F.; Costantini, C.; Poloni, N.; Vender, S.; Callegari, C. 2009: Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: preliminary study Recenti Progressi in Medicina 100(2): 103
Casey, D.E. 1996: Side effect profiles of new antipsychotic agents Journal of Clinical Psychiatry 57(Suppl): 40-45; Discussion 46-52
Niemegeers, C.J.; Awouters, F.; Janssen, P.A. 1990: Serotonin antagonism involved in the antipsychotic effect. Confirmation with ritanserine and risperidone L'Encephale 16(2): 147-151
Dufresne, R.L.; Wagner, R.L. 1988: Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia Journal of Clinical Psychiatry 49(11): 435-438
Engelbrecht, A. 2014: The Medical Cannabidiol Act: what practitioners need to know Iowa Medicine: Journal of the Iowa Medical Society 104(4): 8; 21
Turkanis, S.A.; Cely, W.; Olsen, D.M.; Karler, R. 1974: Anticonvulsant properties of cannabidiol Research Communications in Chemical Pathology and Pharmacology 8(2): 231-246
Sedvall, G.; Nybäck, H. 1973: Effect of clozapine and some other antipsychotic agents on synthesis and turnover of dopamine formed from 14C-tyrosine in mouse brain Israel Journal of Medical Sciences 9 Suppl: 24-30
Borgen, L.A.; Davis, W.M. 1974: Cannabidiol interaction with delta9-tetrahydrocannabinol Research Communications in Chemical Pathology and Pharmacology 7(4): 663-670
Corroon, J.; Felice, J.F. 2019: The Endocannabinoid System and its Modulation by Cannabidiol (CBD) Alternative Therapies in Health and Medicine 25(S2): 6-14
Mincis, M.; Pfeferman, A.; Guimarães, R.X.; Ramos, O.L.; Zukerman, E.; Karniol, I.G.; Carlini, E.A. 1973: Chronic administration of cannabidiol in man. Pilot study Amb: Revista da Associacao Medica Brasileira 19(5): 185-190
Lindamood, C.; Colasanti, B.K. 1980: Effects of delta 9-tetrahydrocannabinol and cannabidiol on sodium-dependent high affinity choline uptake in the rat hippocampus Journal of Pharmacology and Experimental Therapeutics 213(2): 216-221
2003: Choice of an antipsychotic Medical Letter on Drugs and Therapeutics 45(1172): 102-104
Plesnicar, B.K.; Dolzan, V.; Zalar, B. 2008: CYP 2D6 polymorphism and antipsychotic therapy Psychiatria Danubina 20(3): 369-371
Dresse, A. 1996: Neuroleptics or antipsychotic agents Revue Medicale de Liege 51(1): 65-69
Vanden Bussche, G.; Gelders, Y.G.; Heylen, S.L. 1990: Development of new antipsychotic drugs Acta Psiquiatrica y Psicologica de America Latina 36(1-2): 13-25
Vieta, E. 2004: Antipsychotic drugs and pregnancy Medicina clinica 123(13): 517-8; author reply 518
Marks, R.C.; Luchins, D.J. 1991: Antipsychotic medications and seizures Psychiatric Medicine 9(1): 37-52